Anticoagulation

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 14s

Cheng Keat Tan , David Bin-Chia Wu , Seh Yi Joseph Tan , et al

Read time: 18m

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: The RIGHT Study

Yan Yan, Gilles Montalescot,

Watch time: 5m 21s
ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Kerry Layne , Albert Ferro ,

Julia Sikorska , James Uprichard ,

Mario Petretta , Pierluigi Costanzo , Alberto Cuocolo ,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 14s

Frédéric Michard ,

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Jack Wei Chieh Tan , Derek P Chew , Muhamad Ali SK Abdul Kader , et al

Media

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 14s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Yugo Yamashita,

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Watch time: 3h 52m 31s

Media

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 14s

Yugo Yamashita,

View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s
ESC 23: The RIGHT Study

Yan Yan, Gilles Montalescot,

Watch time: 5m 21s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s

Articles

Personalised Antiplatelet Therapy - Whether to Choose Genotype or Phenotype

Laurent Bonello

,

Citation:

European Cardiology 2010;6(4):45–9

DOI:

https://doi.org/10.15420/ecr.2010.8.2.45
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 478
  • Downloads: Downloads 0
  • Citations: 1

Novel Oral Antiplatelet Agents

Suzanne J Baron

,

Robert P Giugliano

,

Citation:

European Cardiology 2011;7(4):294–300

DOI:

https://doi.org/10.15420/ecr.2011.7.4.294
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 236
  • Downloads: Downloads 3

Anticoagulant Therapy in Atrial Fibrillation - Time for a Change?

Raffaele De Caterina

,

Giulia Renda

,

Citation:

European Cardiology 2009;5(2):57–62

DOI:

https://doi.org/10.15420/ecr.2009.5.2.57
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1479
  • Downloads: Downloads 4

Antiplatelet Therapy in Acute Coronary Syndromes

Sasha Koul

,

David Erlinge

,

Citation:

European Cardiology 2010,6(1):58–61

DOI:

https://doi.org/10.15420/ecr.2010.6.1.58
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 425
  • Downloads: Downloads 4